Clinical Trials Directory

Trials / Completed

CompletedNCT06559709

A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant

Implementing a Plant-Based Whole-Foods Meal Delivery Service for Patients Undergoing Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Fred Hutchinson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial evaluates the impact of a plant-based whole-foods delivery service on the microbiome in patients with multiple myeloma undergoing an autologous hematopoietic cell transplant. An autologous hematopoietic cell transplant is a procedure in which blood-forming stem cells (cells from which all blood cells develop) are removed, stored, and later given back to the same person. Loss of microbial diversity within the intestinal tract has been associated with poor outcomes for patients receiving autologous stem cell transplantation. A plant-based whole meal delivery service may increase the intake of foods high in fiber and nutrients therefore improve microbial health during the peri-transplant period. In this pilot study, study investigators will explore the feasibility of this approach.

Detailed description

OUTLINE: Patients receive 3 meals per day and snacks delivered twice weekly and meet with dietitian once weekly on days -7 to 28. Patients undergo blood and stool sample collection on study.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiospecimen CollectionUndergo blood and stool sample collection
OTHERDietary InterventionReceive 3 meals per day and snacks
OTHERDietary InterventionMeet with dietitian
OTHERMedical Chart ReviewAncillary studies
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2024-10-14
Primary completion
2025-08-29
Completion
2025-08-29
First posted
2024-08-19
Last updated
2025-09-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06559709. Inclusion in this directory is not an endorsement.